Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7275650
[patent_doc_number] => 20040235101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Genetic circuit clocked latch'
[patent_app_type] => new
[patent_app_number] => 10/793764
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6209
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793764 | Genetic circuit clocked latch | Mar 7, 2004 | Abandoned |
Array
(
[id] => 586269
[patent_doc_number] => 07439051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Process for utilizing epitopes recognized by natural antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/795676
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29510
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10795676
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/795676 | Process for utilizing epitopes recognized by natural antibodies | Mar 7, 2004 | Issued |
Array
(
[id] => 7406120
[patent_doc_number] => 20040175829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Nucleocapsid-independent specific viral RNA packaging and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/794363
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7486
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794363 | Nucleocapsid-independent specific viral RNA packaging and uses thereof | Mar 4, 2004 | Abandoned |
Array
(
[id] => 7251608
[patent_doc_number] => 20040259073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Charge perturbation signature methods and devices for membrane analysis'
[patent_app_type] => new
[patent_app_number] => 10/794131
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6448
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794131
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794131 | Charge perturbation signature methods and devices for membrane analysis | Mar 4, 2004 | Abandoned |
Array
(
[id] => 7555666
[patent_doc_number] => 08067567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same'
[patent_app_type] => utility
[patent_app_number] => 10/547233
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 17719
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547233 | Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same | Feb 26, 2004 | Issued |
Array
(
[id] => 53450
[patent_doc_number] => 07767392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-03
[patent_title] => 'Gene and protein relating to hepatocellular carcinoma and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/788847
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 58
[patent_no_of_words] => 24101
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10788847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/788847 | Gene and protein relating to hepatocellular carcinoma and methods of use thereof | Feb 26, 2004 | Issued |
Array
(
[id] => 7317758
[patent_doc_number] => 20040224411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Recombinant adeno-associated virus production'
[patent_app_type] => new
[patent_app_number] => 10/789303
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6929
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789303 | Recombinant adeno-associated virus production | Feb 25, 2004 | Issued |
Array
(
[id] => 7233547
[patent_doc_number] => 20050079512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Methods of modulating gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/783672
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22949
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783672 | Methods of modulating gene expression | Feb 19, 2004 | Abandoned |
Array
(
[id] => 7296362
[patent_doc_number] => 20040214333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Loading of cells with antigens by electroporation'
[patent_app_type] => new
[patent_app_number] => 10/781440
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19568
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214333.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781440 | Loading of cells with antigens by electroporation | Feb 17, 2004 | Abandoned |
Array
(
[id] => 7296230
[patent_doc_number] => 20040214281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Methods and compositions for high level expression of a heterologous protein with poor codon usage'
[patent_app_type] => new
[patent_app_number] => 10/777010
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11359
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214281.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777010 | Methods and compositions for high level expression of a heterologous protein with poor codon usage | Feb 10, 2004 | Abandoned |
10/485910 | Methods for the treatment and prognosis of leukemia and other cancer types | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7263839
[patent_doc_number] => 20040241817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function'
[patent_app_type] => new
[patent_app_number] => 10/761435
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 42787
[patent_no_of_claims] => 286
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10761435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/761435 | Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function | Jan 21, 2004 | Issued |
10/018691 | Taxol production via generation of extrachromosomal dnas in the fungus pestalotiopsis | Jan 12, 2004 | Abandoned |
Array
(
[id] => 7183686
[patent_doc_number] => 20040203133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Helper dependent adenoviral vector system and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 10/753962
[patent_app_country] => US
[patent_app_date] => 2004-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12941
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203133.pdf
[firstpage_image] =>[orig_patent_app_number] => 10753962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/753962 | Helper dependent adenoviral vector system and methods for using the same | Jan 6, 2004 | Abandoned |
Array
(
[id] => 5183047
[patent_doc_number] => 20070054401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Composition for intracellular transport of biological particles or macromolecules'
[patent_app_type] => utility
[patent_app_number] => 10/541594
[patent_app_country] => US
[patent_app_date] => 2003-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3949
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054401.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541594 | Composition for intracellular transport of biological particles or macromolecules | Dec 30, 2003 | Abandoned |
Array
(
[id] => 5814832
[patent_doc_number] => 20060084618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Adiponectin promoter and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/540864
[patent_app_country] => US
[patent_app_date] => 2003-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7911
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084618.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540864 | Adiponectin promoter and use thereof | Dec 24, 2003 | Issued |
Array
(
[id] => 7275682
[patent_doc_number] => 20040235133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Large scale production of packaged alphavirus replicons'
[patent_app_type] => new
[patent_app_number] => 10/735046
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9040
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235133.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735046 | Large scale production of packaged alphavirus replicons | Dec 11, 2003 | Issued |
Array
(
[id] => 7233802
[patent_doc_number] => 20040157248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'RecA mutants'
[patent_app_type] => new
[patent_app_number] => 10/733782
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13642
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733782 | RecA mutants | Dec 10, 2003 | Issued |
Array
(
[id] => 7097847
[patent_doc_number] => 20050130306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small molecule regulator'
[patent_app_type] => utility
[patent_app_number] => 10/731961
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12587
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130306.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731961 | Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small molecule regulator | Dec 9, 2003 | Abandoned |
Array
(
[id] => 472330
[patent_doc_number] => 07229825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-12
[patent_title] => 'Double-transfected cell line useful for the identification of transport inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/729861
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10107
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/229/07229825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10729861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/729861 | Double-transfected cell line useful for the identification of transport inhibitors | Dec 4, 2003 | Issued |